Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Astatine-211 based radionuclide therapy: Current clinical trial landscape.
Albertsson P, Bäck T, Bergmark K, Hallqvist A, Johansson M, Aneheim E, Lindegren S, Timperanza C, Smerud K, Palm S. Albertsson P, et al. Among authors: hallqvist a. Front Med (Lausanne). 2023 Jan 6;9:1076210. doi: 10.3389/fmed.2022.1076210. eCollection 2022. Front Med (Lausanne). 2023. PMID: 36687417 Free PMC article. Review.
Positron emission tomography and computed tomographic imaging (PET/CT) for dose planning purposes of thoracic radiation with curative intent in lung cancer patients: A systematic review and meta-analysis.
Hallqvist A, Alverbratt C, Strandell A, Samuelsson O, Björkander E, Liljegren A, Albertsson P. Hallqvist A, et al. Radiother Oncol. 2017 Apr;123(1):71-77. doi: 10.1016/j.radonc.2017.02.011. Epub 2017 Mar 8. Radiother Oncol. 2017. PMID: 28284494 Review.
Positron emission tomography and computed tomographic (PET/CT) imaging for radiation therapy planning in anal cancer: A systematic review and meta-analysis.
Albertsson P, Alverbratt C, Liljegren A, Björkander E, Strandell A, Samuelsson O, Palm S, Hallqvist A. Albertsson P, et al. Among authors: hallqvist a. Crit Rev Oncol Hematol. 2018 Jun;126:6-12. doi: 10.1016/j.critrevonc.2018.03.013. Epub 2018 Mar 31. Crit Rev Oncol Hematol. 2018. PMID: 29759568 Review.
Phase II trial demonstrates the efficacy and safety of individualized, dosimetry-based 177Lu-DOTATATE treatment of NET patients.
Sundlöv A, Gleisner KS, Tennvall J, Ljungberg M, Warfvinge CF, Holgersson K, Hallqvist A, Bernhardt P, Svensson J. Sundlöv A, et al. Among authors: hallqvist a. Eur J Nucl Med Mol Imaging. 2022 Sep;49(11):3830-3840. doi: 10.1007/s00259-022-05786-w. Epub 2022 Apr 22. Eur J Nucl Med Mol Imaging. 2022. PMID: 35451612 Free PMC article. Clinical Trial.
Combinatory analysis of immune cell subsets and tumor-specific genetic variants predict clinical response to PD-1 blockade in patients with non-small cell lung cancer.
Dutta N, Rohlin A, Eklund EA, Magnusson MK, Nilsson F, Akyürek LM, Torstensson P, Sayin VI, Lundgren A, Hallqvist A, Raghavan S. Dutta N, et al. Among authors: hallqvist a. Front Oncol. 2023 Feb 9;12:1073457. doi: 10.3389/fonc.2022.1073457. eCollection 2022. Front Oncol. 2023. PMID: 36844924 Free PMC article.
36 results